Strona główna・Stock List・Novo Nordisk A-S (Class B)

Novo Nordisk A-S (Class B)

Open

259.05 -7.79

Buy Sell

Overview

Share price change

24h

Current

Min

260.6

Max

281.89

Key metrics
By Trading Economics
Income	-28B 21B
Sales	-18B 78B
P/E Sector Avg	10.646 56.432
EPS	6.18
Dividend yield	4.17
Profit margin	26.742
Employees	66,700
EBITDA	-31B 39B

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+9.53% upside

Dividends
By Acuity
Dividend yield Sector Avg	4.17% 2.27%
Next Earnings	4 lis 2026

Market Stats
By TradingEconomics
Market Cap	-128B 1.2T
Previous open	266.84
Previous close	259.05

Novo Nordisk A-S (Class B) Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

20 wrz 2026, 23:51 UTC

BoJ Meeting Minutes on September 27 Expected to Influence Japan's Interest Rate Outlook Amid Global Economic Uncertainties.

20 wrz 2026, 23:11 UTC

PBOC Holds Loan Prime Rate Steady at 3.00% Amid Economic Caution and Mixed Signals in China

20 wrz 2026, 23:01 UTC

Macro News

Correlated Moves

The Dow Jones Index is advancing as the People's Bank of China maintains its Loan Prime Rates amid cautious market conditions and geopolitical tensions.

20 wrz 2026, 23:01 UTC

Correlated Moves

Macro News

The S&P 500 Index is advancing amid macroeconomic developments, including China's unchanged Loan Prime Rates and mixed industrial production and retail sales data.

20 wrz 2026, 23:01 UTC

Macro News

Correlated Moves

The Nasdaq 100 Index is advancing, supported by the Russell 2000's rise and the People's Bank of China's decision to maintain its Loan Prime Rate at 3.00%.

20 wrz 2026, 23:01 UTC

Correlated Moves

Macro News

The Russell 2000 Index is modestly higher, reflecting a stable market backdrop amid China's unchanged Loan Prime Rate and geopolitical tensions.

20 wrz 2026, 23:00 UTC

Macro News

Oil (WTI) is advancing amid heightened geopolitical tensions following Houthi attacks in Saudi Arabia and ongoing U.S. energy policy discussions, despite earlier session pullbacks.

20 wrz 2026, 23:00 UTC

The EUR/NOK is declining as trading resumes for the week, influenced by ongoing geopolitical tensions in the Middle East and U.S.-Iran relations.

20 wrz 2026, 23:00 UTC

The EUR/CHF is slightly lower in early trading this week, reflecting routine fluctuations amid ongoing geopolitical tensions, particularly in the Middle East.

20 wrz 2026, 23:00 UTC

The EUR/CZK is slightly lower as trading resumes for the week, reflecting geopolitical tensions affecting financial markets despite remaining near the upper end of its one-month range.

20 wrz 2026, 23:00 UTC

Avalanche is experiencing a sharp increase in value, maintaining a position well above its 20-day moving average amid ongoing geopolitical tensions.

20 wrz 2026, 22:51 UTC

U.S. 30-Year Mortgage Rate Hits Highest Level Since May at 6.97%, Sparking Concerns Over Housing Demand Amid Rising Treasury Yields and Inflation Fears

20 wrz 2026, 22:51 UTC

Chicago Fed National Activity Index Release on September 21, 2026, Anticipates Continued Economic Uncertainty Amid Recent Volatility.

20 wrz 2026, 22:11 UTC

UK Consumer Confidence Index Set for Release Amid Mixed Sentiment and Economic Concerns, Forecast at -16.0

20 wrz 2026, 22:01 UTC

Correlated Moves

The AUD/USD is slightly lower in early trading, reflecting a cautious investor outlook amid ongoing Middle East conflict and recent interest rate hikes.

20 wrz 2026, 22:00 UTC

The EUR/PLN is advancing in early trading, reflecting a notable increase since Friday's close amid ongoing geopolitical tensions and central bank interest rate hikes.

20 wrz 2026, 21:21 UTC

Australia's S&P Global Manufacturing PMI Flash set for September 22, with cautious optimism amid global economic pressures.

20 wrz 2026, 21:21 UTC

Australia's S&P Global Services PMI Flash set for September 22, with cautious optimism amid global market influences.

20 wrz 2026, 21:01 UTC

Brazil's Central Bank to Release Key Market Readout on Interest Rates and Economic Forecasts on September 21, 2026.

20 wrz 2026, 20:51 UTC

UK CBI Distributive Trades Forecasts Sharp Decline in Retail Sales Sentiment at -50.0 Amid Ongoing Consumer Spending Downturn

20 wrz 2026, 20:21 UTC

UK Factory Orders Show Resilience with Improved Order Book Balance, Yet Forecasts Indicate Continued Decline Amid Economic Challenges.

20 wrz 2026, 20:21 UTC

API Crude Oil Stock Change Report on September 22, 2026, Expected to Reveal Rising U.S. Inventories Amid Geopolitical Tensions Impacting Market Sentiment.

20 wrz 2026, 19:21 UTC

South Korea's Consumer Confidence Index Release on September 22 Expected to Reflect Cautious Optimism Amid Economic Volatility.

20 wrz 2026, 18:51 UTC

Germany's Ifo Business Climate Index set to release with a forecast of 89.2, reflecting cautious optimism amid geopolitical tensions and inflationary pressures.

20 wrz 2026, 18:51 UTC

South Africa's Inflation Rate MoM Release on September 23, 2026 Expected to Reflect Global Economic Trends Amid Rising Concerns.

20 wrz 2026, 18:51 UTC

South Africa's Inflation Rate Release on September 23, 2026, Expected to Reflect Economic Pressures Amid Rising Costs and Geopolitical Tensions.

20 wrz 2026, 18:41 UTC

Cautious Optimism for Euro Area Manufacturing as S&P Global PMI Flash Set to Show Growth at 52.9 Amid Geopolitical Challenges

20 wrz 2026, 18:41 UTC

Spain's Balance of Trade Data Set for Release Amidst Ongoing Trade Deficits and Rising Import Costs, Raising Inflation Concerns in the Eurozone.

20 wrz 2026, 18:41 UTC

Swiss National Bank Expected to Maintain Zero Interest Rate Amid Subdued Inflation and Modest Economic Growth

20 wrz 2026, 18:41 UTC

French Services PMI Flash Expected at 48.5 Amid Political and Economic Concerns, Signaling Continued Contraction

Peer Comparison

Price change

Novo Nordisk A-S (Class B) Forecast

Price Target

By TipRanks

9.53% upside

12 Months Forecast

Average 1,162.73 DKK 9.53%

High 1,550 DKK

Low 720 DKK

Based on 11 Wall Street analysts offering 12 month price targets forNovo Nordisk A-S (Class B) - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

11 ratings

Buy

Hold

Sell

Based on 11 analysts giving stock ratings to Novo Nordisk A-S (Class B) - Dist in the past 3 months.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Novo Nordisk A-S (Class B)

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with UNICEF to tackle childhood obesity; and with Valo Health, Inc. to discover and develop novel drug programmes for cardiometabolic space. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.